RhumbLine Advisers’s LB Pharmaceuticals LBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding LBRX
RhumbLine Advisers's LBRX Position: Q3 2026 in Review
RhumbLine Advisers increased its LB Pharmaceuticals (LBRX) stake by 1.9% in Q3 2026, buying an estimated $21.7K and bringing the position to 28,314 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2223.
RhumbLine Advisers first reported a position in LBRX in Q4 2025 and has held it in 4 quarters since. 146 funds tracked by Wall St. Rank hold LBRX as of Q3 2026.
- RhumbLine Advisers held 28,314 shares of LB Pharmaceuticals worth $1.09M as of Q3 2026.
- RhumbLine Advisers bought 525 LB Pharmaceuticals shares in Q3 2026, an estimated $21.7K.
- LB Pharmaceuticals made up ﹤0.01% of RhumbLine Advisers's portfolio in Q3 2026, its #2223 holding.
- RhumbLine Advisers first reported a position in LB Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
- 146 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q3 2026.
Based on RhumbLine Advisers's 13F filing for Q3 2026, filed 10 Nov 2026.